Progressive Multifocal Leukoencephalopathy trends

Progressive Multifocal Leukoencephalopathy related content:

Progressive Multifocal Leukoencephalopathy stories:

  • US warns of risk rise with more Tysabri infusions

    Feb 5th, 2010 - Reuters

    for tysabri will be updated to warn of the higher risk with more treatment, the food and drug administration said. elan corp co-markets the drug. the fda said the warning was based on 31 confirmed cases of progressive multifocal leukoencephalopathy (pml

  • FDA Adds PML Risk to MS Drug Label

    Feb 5th, 2010 - MedPage Today

    washington -- a warning of a risk of progressive multifocal leukoencephalopathy has been added to the label for the multiple sclerosis drug natalizumab (tysabri), the fda announced. the warning notes that the risk of pml increases with the number

  • FDA: Rare Brain Infection Rises With Tysabri Doses

    Feb 5th, 2010 - Wall Street Journal

    increase, the u.s. food and drug administration said in a letter to doctors friday. the fda said it has confirmed 31 cases of progressive multifocal leukoencephalopathy, or pml, a rare brain infection, in patients taking the multiple sclerosis

  • FDA warns of brain risks with frequent Tysabri use

    Feb 5th, 2010 - Telegram

    of progressive multifocal leukoencephalopathy, or pml, which can cause swelling of the brain that is usually fatal. it is mostly seen in patients with immune deficiencies. the biotech drug is marketed by cambridge, mass.-based biogen idec inc. and irish

More stories ...

Google Search:

Loading...

Progressive Multifocal Leukoencephalopathy videos from YouTube:

More videos ...